DFDA

Clinical Trials for Type 2 Diabetes

Focusing on: Sulfonylureas

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Specify a medical condition you are interested in.

Specify a drug, device, or procedure if you are looking for trials for a specific intervention.

Displaying 10 of 359 results.

Page 1 of 36
AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes
Completed
Study Type: INTERVENTIONAL
Phase: PHASE3
Enrollment: 544
Age: 18 Years - 75 Years
Gender: ALL
Locations: GSK Investigational Site; GSK Investigational Site; +140 more
View Study Details
Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
Completed
Study Type: INTERVENTIONAL
Phase: PHASE4
Enrollment: 114
Age: 18 Years - 80 Years
Gender: ALL
Locations: N/A
Has Results
View Study Details
Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes
UnknownLast Known: ENROLLING_BY_INVITATION
Interventions:Sulfonylurea
Study Type: INTERVENTIONAL
Phase: PHASE4
Enrollment: 30
Age: 2 Years - 95 Years
Gender: ALL
Locations: Department of Pediatrics and Adolescents, Haukeland University Hospital, and Department of Clinical Science, Faculty of Medicine, University of Bergen
View Study Details
Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)
Completed
Interventions:SulphonylureaMetformn
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 726
Age: From 30 Years
Gender: ALL
Locations: N/A
Has Results
View Study Details
The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes
Completed
Interventions:Sulfonylurea
Study Type: INTERVENTIONAL
Phase: PHASE2
Enrollment: 12
Age: From 18 Years
Gender: ALL
Locations: Department of Internal Medicine, Gentofte University Hospital
Has Results
View Study Details
A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
Completed
Study Type: INTERVENTIONAL
Phase: PHASE3
Enrollment: 774
Age: From 18 Years
Gender: ALL
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.; For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.; +28 more
Has Results
View Study Details
Genetic Variants Replication Study Associated With Dependence on Sulfonylurea in Participants With Type 2 Diabetes
Completed
Study Type: INTERVENTIONAL
Phase: PHASE4
Enrollment: 58
Age: From 19 Years
Gender: ALL
Locations: Seoul National University Hospital
View Study Details
The OBSTACLE Hypoglycemia Study (MK-0000-158)
Completed
Conditions:Type 2 Diabetes
Interventions:Sulfonylurea
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 1069
Age: 18 Years - 75 Years
Gender: ALL
Locations: N/A
Has Results
View Study Details
Study of Sulphonylurea Synergy With DPP4 Inhibitors
Completed
Conditions:Type 2 Diabetes
Study Type: INTERVENTIONAL
Phase: NA
Enrollment: 30
Age: 40 Years - 80 Years
Gender: ALL
Locations: Ninewells Hospital and Medical School
View Study Details
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
Completed
Study Type: INTERVENTIONAL
Phase: PHASE3
Enrollment: 361
Age: From 20 Years
Gender: ALL
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.; For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.; +13 more
Has Results
View Study Details